A study (Zhang, 2022) has shown that glioma cell lines and samples have higher expression levels of lncRNA-NEAT1, which may function as an oncogene to encourage glioma cell growth both in vivo as well as in vitro. The gene discussed is NEAT1; the disease is central nervous system cancer.